foxo4-dri senolytic peptide human trial 2024 FOX04-DRI FOXO4-DRI part 1 , #peptide
FOXO4 DRI part 1 , #peptide #molecule #research #health #information FOXO4 DRI FOXO4 p53 Peptide Peptagon The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


